JPH0259836B2 - - Google Patents
Info
- Publication number
- JPH0259836B2 JPH0259836B2 JP14666282A JP14666282A JPH0259836B2 JP H0259836 B2 JPH0259836 B2 JP H0259836B2 JP 14666282 A JP14666282 A JP 14666282A JP 14666282 A JP14666282 A JP 14666282A JP H0259836 B2 JPH0259836 B2 JP H0259836B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- spot
- benzyl group
- toluene
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Saccharide Compounds (AREA)
Description
【発明の詳細な説明】
本発明は、新規オリゴマンノシド及びその製造
法に関するものであり、更に詳細には、α1−2
結合及びα1−3結合を有する直鎖状マンナン及
びその製造法に関するものである。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel oligomannoside and a method for producing the same.
The present invention relates to a linear mannan having a bond and an α1-3 bond, and a method for producing the same.
マンナンは高等植物から微生物まで広く分布し
ている多糖である。近年、それらの化学構造の研
究が進歩し、いくつかのくり返し単位の構造式が
提示されている。例えば、酵母マンナンやイモチ
菌のマンナンは、細胞の表層に存在しているプロ
テオマンナンであり(T.Nakajima、H.Sasaki、
M.Sato、K.Tamari and K.Matsuda、J.
Biochem.(Tokyo)82、1657〜1662)複雑に分岐
した構造が考えられている。これらのマンナン
は、表層に存在していることから生物間の認識現
象にも関与している可能性が大きい。また、いく
つかのマンナンについては、抗腫瘍活性が報告さ
れている。本発明者らは、これらの生物学的機能
や抗腫瘍活性とマンナン構造との相関の解明を目
的として、正確な構造を有するオリゴマンノシド
の合成研究を行つている。 Mannan is a polysaccharide that is widely distributed from higher plants to microorganisms. In recent years, research on their chemical structures has progressed, and structural formulas of several repeating units have been proposed. For example, yeast mannan and potato mannan are proteomannans that exist on the surface of cells (T. Nakajima, H. Sasaki,
M. Sato, K. Tamari and K. Matsuda, J.
(Biochem. (Tokyo) 82, 1657-1662) A complex branched structure is considered. Since these mannans exist on the surface layer, it is highly likely that they are also involved in recognition phenomena between organisms. Furthermore, antitumor activity has been reported for some mannans. The present inventors are conducting research on the synthesis of oligomannosides having accurate structures, with the aim of elucidating the correlation between these biological functions, antitumor activities, and mannan structure.
本発明者らは既に、2,6−および3,6−分
枝のマンナン構造の合成法(特開昭57−72996号、
特開昭57−72997号)、α1−2結合を有する直鎖
状マンナンの合成法(特開昭57−146797号)を確
立しているが、更にキヤンジダ・アルビカンス
(Candida albicans)やサツカロミセス・セレビ
ジアエ(Saccharomyces cerevisiae)に見られ
る下記の直鎖状マンナンの合成法につき鋭意研究
を行い本発明を完成するに至つた。 The present inventors have already reported a method for synthesizing 2,6- and 3,6-branched mannan structures (Japanese Patent Application Laid-Open No. 72996/1983).
JP 57-72997) and a method for synthesizing linear mannans having α1-2 bonds (JP 57-146797). The present invention has been completed through extensive research into the following method for synthesizing linear mannan found in Saccharomyces cerevisiae.
Man α1→3Man α1(→2Man α1)→o2Man
(n=0 または2)
本発明は、特開昭57−146797号記載の方法によ
り合成されるα1−2結合を有する3糖を糖受容
体とし、これに2種の単糖性糖供与体を順次反応
させることにより、α1−2結合とα1−3結合を
有する5糖直鎖状マンナンを合成するものであ
る。以下、本発明を詳述する。Man α1 → 3Man α1 (→2Man α1) → o 2Man (n = 0 or 2) By sequentially reacting this with two types of monosaccharide sugar donors, a pentasaccharide linear mannan having an α1-2 bond and an α1-3 bond is synthesized. The present invention will be explained in detail below.
本発明は一般式
(式中、Rは水素またはベンジル基を表わし、
R1、R2、R3、R4は水素、ベンジル基またはアセ
チル基を表わし、同一でも異なつていてもよい。)
で表わされるマンノペンタオース及びその製造法
に関するものである。上記マンノペンタオース
は、
式 (1)
(Rはベンジル基を表わす)
で表わされる化合物(1)と、式(2)
(Rはベンジル基、Acはアセチル基、Xはハロ
ゲン原子を表わす)
で表わされる化合物(2)を反応させて、式(3)
で表わされる化合物(3)を得、これを脱アセチル化
して得られる化合物(4)と、式(6)
(R1、R2、R3、R4はベンジル基またはアセチル
基、Xはハロゲン原子を表わす)
で表わされる化合物を反応させ、必要により脱ア
セチル化し、更に脱ベンジル化することにより得
られる。 The present invention is based on the general formula (In the formula, R represents hydrogen or a benzyl group,
R 1 , R 2 , R 3 and R 4 represent hydrogen, a benzyl group or an acetyl group, and may be the same or different. ) and its production method. The above mannopentaose is expressed by the formula (1) (R represents a benzyl group) Compound (1) represented by and formula (2) (R is a benzyl group, Ac is an acetyl group, and X is a halogen atom) by reacting the compound (2) represented by the formula (3). Compound (3) represented by is obtained, and compound (4) obtained by deacetylating this and formula (6) (R 1 , R 2 , R 3 , R 4 are benzyl groups or acetyl groups, and X represents a halogen atom) It is obtained by reacting a compound represented by the following formula, deacetylating if necessary, and further debenzylating.
本発明の出発物質である3糖受容体(1)は、たと
えば次の工程により得られる。すなわち、単糖受
容体化合物(7)
(Bnはベンジル基を表わす)
を、単糖供与体化合物(8)
と反応させて2糖化合物(9)を得、
該化合物(9)を脱アセチル化して化合物(10)とし、
更に糖供与体化合物(8)を反応させて3糖化合物(11)
とし、これを脱アセチル化することによ得られ
る。 The trisaccharide receptor (1), which is the starting material of the present invention, can be obtained, for example, by the following steps. i.e., monosaccharide receptor compounds (7) (Bn represents a benzyl group) is a monosaccharide donor compound (8) A disaccharide compound (9) was obtained by reacting with The compound (9) is deacetylated to form a compound (10),
Furthermore, a sugar donor compound (8) is reacted to form a trisaccharide compound (11).
It can be obtained by deacetylating this.
本発明における糖供与体化合物(2)は、たとえば
次の工程により得られる。α−D−マンノースを
アリルアルコール/アセチルクロライドで処理し
てアリルα−D−マンノピラノシド(17)とし、こ
れをピリジン中、トリチルクロライドで処理して
6位をトリチル化し(化合物(18))、(n−
Bu3Sn)2O、Bu4NCl及びアリルブロマイドで処
理して3位をアリル化した後(化合物(19))、酢
酸により脱トリチル化して化合物(20)を得、
DMF中、NaH/ベンジルブロマイドで処理して
2、4、6位をベンジル化し(化合物(21))、次
いで酢酸中、PdCl2/AcONaで処理して脱アリル
化し(化合物(22))、更にAc2O/ピリジンにより
ベンジル化後(化合物(23))、CH2Cl2中、HClガ
スにより処理してハイライド(2)を得る。 The sugar donor compound (2) in the present invention can be obtained, for example, by the following process. α-D-mannose was treated with allyl alcohol/acetyl chloride to give allyl α-D-mannopyranoside (17), which was then treated with trityl chloride in pyridine to tritylate the 6-position (compound (18)). n-
After treatment with Bu 3 Sn) 2 O, Bu 4 NCl and allyl bromide to allylate the 3-position (compound (19)), detritylation with acetic acid yielded compound (20),
The 2, 4, and 6 positions were benzylated by treatment with NaH/benzyl bromide in DMF (compound (21)), and then deallylated by treatment with PdCl 2 /A c ON a in acetic acid (compound (22)). ), and further benzylated with Ac 2 O/pyridine (compound (23)), followed by treatment with HCl gas in CH 2 Cl 2 to obtain hydride (2).
本発明における他方の糖供与体化合物としては
一般式(6)
で表わされる任意の保護糖ハライドを使用するこ
とができる。ハライドとしては、クロライド、ブ
ロマイド、アイオダイドが好ましく、保護基とし
ては、アセチル基、ベンジル基等を使用するのが
一般的である。R1〜R4のうち1個をアセチル基、
他をベンジル基で保護しておけば、前記糖鎖伸長
反応により得られる5糖を脱アセチル化した後、
更に糖鎖を伸長させることができる。また、R1
〜R4のうち2個をアセチル基、他をベンジル基
で保護しておけば、分枝した糖鎖を有するオリゴ
糖を合成することができる。一般式(6)で表わされ
る化合物の例としては、R1〜R4がベンジル基で
あるもの、R1〜R4がアセチル基であるもの、R1
がアセチル基、R2〜R4がベンジル基である化合
物(8)、R2がアセチル基、他がベンジル基である
化合物(2)、R4がアセチル基、他がベンジル基で
ある化合物(24)などが挙げられる。上記化合物(8)
の製法は特開昭57−146797号に記載されている。
化合物(24)はたとえば次の工程により合成され
る。すなわち、前記アリル6−0−トリチル−α
−D−マンノシド(18)をDMF中、NaH/ベンジ
ルブロマイドで処理して2、3、4位をベンジル
化し(化合物(25))、酢酸により脱トリチル化後
(化合物(26))、無水酢酸(Ac2O)/ピリジンで
アセチル化(化合物(27))、更に、酢酸中、
PdCl2/Ac ONaで処理して脱アリル化し(化合
物(28))、次いでCH2Cl2中、チオニルクロライド
処理することにより得られる。 The other sugar donor compound in the present invention is represented by the general formula (6) Any protected sugar halide represented by can be used. As the halide, chloride, bromide, and iodide are preferred, and as the protecting group, acetyl group, benzyl group, etc. are generally used. One of R 1 to R 4 is an acetyl group,
If the others are protected with a benzyl group, after deacetylating the pentasaccharide obtained by the sugar chain elongation reaction,
Furthermore, the sugar chain can be extended. Also, R 1
If two of ~R 4 are protected with acetyl groups and the others with benzyl groups, oligosaccharides having branched sugar chains can be synthesized. Examples of compounds represented by general formula (6) include those in which R 1 to R 4 are benzyl groups, those in which R 1 to R 4 are acetyl groups, and R 1
Compound (8) where is an acetyl group and R 2 to R 4 are benzyl groups, Compound (2) where R 2 is an acetyl group and the others are benzyl groups, Compound (2) where R 4 is an acetyl group and the others are benzyl groups ( 24) etc. The above compound (8)
The manufacturing method is described in JP-A-57-146797.
Compound (24) is synthesized, for example, by the following steps. That is, the allyl 6-0-trityl-α
-D-Mannoside (18) was treated with NaH/benzyl bromide in DMF to benzylate the 2, 3, and 4 positions (compound (25)), detritylated with acetic acid (compound (26)), and acetic anhydride. Acetylation with (Ac 2 O)/pyridine (compound (27)), and further in acetic acid,
Obtained by deallylation by treatment with PdCl 2 /Ac ONa (compound (28)), followed by treatment with thionyl chloride in CH 2 Cl 2 .
化合物(4)に化合物(8)を反応させると5糖化合物
(29)が得られ、これを脱アセチル化すれば化合物
(30)が、更に脱ベンジル化すれば化合物(31)がそ
れぞれ得られる。また、化合物(4)に化合物(24)を
反応させると5糖化合物(32)が得られ、これを脱
アセチル化すれば化合物(33)が、更に脱ベンジル
化すれば化合物(31)がそれぞれ得られる。 Reacting compound (4) with compound (8) yields pentasaccharide compound (29), which is deacetylated to yield compound (30), and further debenzylated to yield compound (31). . In addition, when compound (4) is reacted with compound (24), pentasaccharide compound (32) is obtained, and when this is deacetylated, compound (33) is obtained, and when further debenzylated, compound (31) is obtained. can get.
3糖受容体(1)または4糖受容体(4)と、糖供与体
化合物(2)、(8)または(24)等のハライドとの反応は
1,2−ジクロルエタン、ジクロルメタン、クロ
ロホルム、ニトロメタン、ベンゼン、トルエン等
の溶媒中、温度−30℃〜150℃、時間1〜8時間
程度で、HgBr2、Hg(CN)2、AgOSO2CF3、
Ag2CO3、Ag2O、AgClO4等の触媒を用いて行わ
れる。この際、反応中生成するHBrなどの酸を
除去する目的でモレキユラーシーブ4Aを加えて
反応させるのが好ましい。 The reaction between the trisaccharide acceptor (1) or the tetrasaccharide acceptor (4) and a halide such as the sugar donor compound (2), (8) or (24) can be performed using 1,2-dichloroethane, dichloromethane, chloroform, or nitromethane. , HgBr2 , Hg ( CN) 2 , AgOSO2CF3 ,
This is carried out using a catalyst such as Ag 2 CO 3 , Ag 2 O, AgClO 4 or the like. At this time, it is preferable to add molecular sieve 4A to the reaction mixture for the purpose of removing acids such as HBr generated during the reaction.
化合物(3)、(29)及び(32)の脱アセチル化反応は、
ナトリウムメトキシド、ナトリウムエトキシド、
トリエチルアミンなどの三級有機塩基等の触媒を
用いて、メタノール、エタノール、n−及びiso
−プロパノール、水又はそれらの混合溶媒中温度
−30℃〜100℃、0.5時間〜30時間で十分に進行す
る。 The deacetylation reaction of compounds (3), (29) and (32) is
sodium methoxide, sodium ethoxide,
Using catalysts such as tertiary organic bases such as triethylamine, methanol, ethanol, n- and iso
- The process proceeds satisfactorily in propanol, water, or a mixed solvent thereof at a temperature of -30°C to 100°C for 0.5 to 30 hours.
化合物(4)、(30)、及び(33)の脱ベンジル化反応
は、これらの化合物を、水−エタノール、THF
−エタノール、エタノール、メタノール、酢酸、
THF−水、ジオキサン−水、DMF等の溶媒又は
混合溶媒に溶解し、Pd/C等を触媒として常圧
又は加圧水素添加することにより行われる。反応
温度は0℃〜100℃反応時間は1〜100時間程度が
適当である。 The debenzylation reaction of compounds (4), (30), and (33) was performed by converting these compounds into water-ethanol, THF
-ethanol, ethanol, methanol, acetic acid,
This is carried out by dissolving in a solvent or mixed solvent such as THF-water, dioxane-water, DMF, etc., and hydrogenating at normal pressure or under pressure using Pd/C or the like as a catalyst. Appropriate reaction temperature is 0°C to 100°C and reaction time is approximately 1 to 100 hours.
なお、上記の工程において得られる化合物(2)、
(3)、(4)、(18)、(19)(20)、(21)、(22)、(23)、(24)、
(25)、(26)、(27)、(28)、(29)、(30)、(31)、(32)
及
び(33)はいずれも本発明者らにより初めて合成さ
れた新規化合物である。 In addition, the compound (2) obtained in the above step,
(3), (4), (18), (19)(20), (21), (22), (23), (24),
(25), (26), (27), (28), (29), (30), (31), (32)
and (33) are both novel compounds synthesized for the first time by the present inventors.
本発明の上記工程を以下概略的に示す。 The above steps of the present invention will be schematically illustrated below.
(1)
3糖受容体+
(2)
単糖供与体→
(3)
4糖脱アセチル化
――――――→
(4)脱ベンジル化
――――――→
(5)
(4)
4糖受容体+
(8)
単糖供与体→
(29)
5糖脱アセチル化
――――――→
(30)脱ベンジル化
――――――→
(31)
(4)
4糖受容体+
(24)
単糖供与体→
(32)
5糖脱アセチル化
――――――→
(33)脱ベンジル化
――――――→
(31)
本発明により得られる上記の新規化合物は、抗
腫瘍性等の生理活性を有するマンナンを合成する
際の中間体として、又該マンナンの生物学的意義
や機能を解明する際の試薬としての有用性を有す
るものである。(1) Trisaccharide acceptor + (2) Monosaccharide donor → (3) Tetrasaccharide deacetylation――――――→ (4)Debenzylation――――――→ (5) (4) Tetrasaccharide acceptor + (8) Monosaccharide donor → (29) Pentasaccharide deacetylation――――――→ (30) Debenzylation――――――→ (31) (4) Tetrasaccharide acceptor body + (24) Monosaccharide donor → (32) Pentasaccharide deacetylation---------→ (33) Debenzylation---------→ (31) The above-mentioned novel compound obtained by the present invention is useful as an intermediate in the synthesis of mannan having physiological activities such as antitumor properties, and as a reagent in elucidating the biological significance and function of the mannan.
以下実施例により本発明を更に詳細に説明する
が、これらは何ら本発明の範囲を制限するもので
はない。 The present invention will be explained in more detail with reference to Examples below, but these are not intended to limit the scope of the present invention in any way.
なお、以下に示す参考例及び実施例はそれぞれ
次の化合物の合成工程を示すものである。 Note that the reference examples and examples shown below show the synthesis steps of the following compounds, respectively.
参 考 例 工 程
1 α−D−マンノース → (17)
2 (17) → (18)
3 (18) → (25)
4 (25) → (26)
5 (26) → (27)
6 (27) → (28)
7 (28) → (24)
実 施 例
1 (1) + (2) → (24)
2 (3) → (4)
3 (4) + (8) → (29)
4 (29) → (30)
5 (30) → (31)
6 (4) +(24) + (32)
7 (32) → (33)
参考例 1
アリルアルコール500mlにアセチルクロライド
25mlを加え窒素置換後1時間室温で撹拌する。氷
冷下α−Dマンノース100g(0.55M)を加え室
温で9日間撹拌するとtlc上(クロロホルム:メ
タノール2:1)で原料のRf0.15のスポツトがほ
ぼ消失し、新たにRf0.57のスポツトが現れた。ト
リエチルアミン100mlを加えた後、室温で30分間
撹拌し、溶媒除去して172gのシロツプ状の粗生
成物(17)を得た。 Reference Example Process 1 α-D-Mannose → (17) 2 (17) → (18) 3 (18) → (25) 4 (25) → (26) 5 (26) → (27) 6 (27 ) → (28) 7 (28) → (24) Example 1 (1) + (2) → (24) 2 (3) → (4) 3 (4) + (8) → (29) 4 ( 29) → (30) 5 (30) → (31) 6 (4) + (24) + (32) 7 (32) → (33) Reference example 1 Acetyl chloride in 500 ml of allyl alcohol
Add 25 ml and stir at room temperature for 1 hour after purging with nitrogen. After adding 100 g (0.55 M) of α-D mannose under ice-cooling and stirring at room temperature for 9 days, the Rf0.15 spot in the raw material almost disappeared on TLC (chloroform:methanol 2:1), and a new Rf0.57 spot appeared. appeared. After adding 100 ml of triethylamine, the mixture was stirred at room temperature for 30 minutes and the solvent was removed to obtain 172 g of a syrupy crude product (17).
参考例 2
得られた(17)の全量をピリジン500mlに溶解し、
トリチルクロライド180g(0.65M)を加え窒素
置換後室温で1晩撹拌するとtlc(トルエン:酢酸
エチル2:1)上で原料の原点附近のスポツトが
ほぼ消失し、新たにRf0.35のスポツトが現れた。
溶媒除去して得られた約400gのシロツプ状物質
をシリカゲル500gのフラツシユクロマトグラフ
イー(トルエン500ml→トルエン:酢酸エチルル
2:1)で分離し、302gの粉状の粗生成物(18)
を得た。(α−D−マンノースから95%)
〔α〕D=+2.1゜(C=0.72、CHCl3)
参考例 3
(18)2.21g(5mM)をDMF100mlに溶解し、氷
冷下50%NaH0.76(33mM)を加え室温で1時間
撹拌する。更に氷冷下でベンジルブロマイド2.7
mlを滴下し室温で3時間撹拌するとtlc(トルエ
ン)上で原料の原点のスポツトが消失し、新たに
Rf0.50のスポツトが現れた。氷冷下、メタノール
10mlを加え、室温で30分間撹拌する。溶媒除去後
水50mlを加えた後エーテル50mlで3回抽出する。
水、飽和食塩水で洗浄後、MgSO4で脱水後溶媒
除去し、シリカゲル100gのフラツシユクロマト
グラフイー(トルエン)で単離し、3.0gのシロ
ツプ状物質(25)を得た。(80%)
C49H48O6として、 C80.30 H 6.60
測 定 値 C80.46 H 6.56
〔α〕D=+18.3゜(C=0.88、CHCl3)
参考例 4
(25)25gを酢酸400mlに溶解し、水100mlを加え
100℃で45分間撹拌するとtlc(トルエン)上で原
料のRf0.50のスポツトが消失し、新たにRf0.10の
スポツトがRf0.90のスポツトと共に現れた。溶媒
除去後300gのフラツシユクロマトグラフイー
(トルエン:酢酸エチル4:1)でRf0.10のスポ
ツトを単離し、15gのシロツプ状物質(26)を得
た。(94%)
C30H34O6として、C 73.45 H 6.99
C 73.22 H 6.99
〔α〕D=+37.0゜(C=0.45、CHCl3)
参考例 5
(26)15gを無水酢酸:ピリジン1:2の混合溶
液150mlに溶解し室温で1晩撹拌するとtlc(トル
エン:酢酸エチル5:1)上で原料のRf0.29のス
ポツトが消失し新たにRf0.56の単一のスポツトが
現れた。溶媒除去後、飽和重曹水500mlを加え、
クロロホルム400mlで3回抽出後、水で2回洗浄
しMgSO4で脱水後溶媒除去し、更にエタノール、
トルエンで3回共沸し16.5gのシロツプ状物質(2
7)を得た。(定量的)
〔α〕D=+8.4゜(C=1.2、CHCl3)
C32H36O7として、C 72.16 H 6.81
測 定 値 C 71.48 H 6.57
参考例 6
(27)5gを酢酸40mlに溶解しpdCl21.2g酢酸ナ
トリウム1.25g、水2mlを加え、室温で3日間撹
拌するとtlc(トルエン:酢酸エチル5:1)で原
料のRf0.66のスポツトがほぼ消失し新たにRf0.12
のスポツトが現れた。ケイ藻土(FC)過後溶
媒除去し、水300mlを加えた後酢酸エチル300mlで
3回抽出する。飽和重曹水、水、飽和食塩水で洗
浄後MgSO4で乾燥し、溶媒除去後シリカゲル100
gのフラツシユクロマトグラフイー(トルエン:
酢酸エチル3.5:1)で単離し、4.1gのシロツプ
状物質(28)を得た。(88%)
〔α〕D=+10.3(C=0.5、CHCl3)
C29H32O7・2/3CH3COOH として
C 68.37 H 6.56
測 定 値 C 68.34 H 6.52
参考例 7
(28)2gをジクロルメタン40mlに溶解し
DMF0.1mlチオニルクロライド4mlを加えて1晩
撹拌すると、tlc(トルエン:酢酸エチル5:1)
上でわずかの原料のRf0.16のスポツトと共に、新
たにRf0.71のスポツトが現れた。溶媒除去後シリ
カゲル10gのフラツシユクロマトグラフイー(ト
ルエン:酢酸エチル7:1)により1.4gのシロ
ツプ状物質(24)を得た。(68%)
〔α〕D=+59.3゜(C=0.77 CHCl3)
実施例 1
30ml褐色二口フラスコにモレキユラーシーブズ
4A末2gを入れ減圧下180℃で6時間撹拌する。
室温に冷却後トルエン10ml溶のAgOSO2CF3200
mgを加え、減圧下50℃で溶媒除去する。窒素置換
後ジクロルエタン15ml溶の化合物(1)290mg
(0.208mM)を注入し、−15℃に冷却後(2)110mg
(0.215mM1.03eq)をジクロルエタン5mlに溶解
し滴下注入する。室温で3時間撹拌するとtlc(ト
ルエン:酢酸エチル10:1)上で痕跡の(1)の
Rf0.38のスポツトと共に新たにRf0.64のスポツト
が現れた。−15℃に冷却し、ジクロルエタン2ml
溶の(2)20mg(0.067mM)を加え、室温で1晩撹
拌するとtlc(同上)上でほぼ単一のRf0.64のスポ
ツトが現れた。過後溶媒除去し、20gシリカゲ
ルのフラツシユクロマトグラフイーにより単離
し、310mgのシロツプ状物質(3)を得た。(80%)
C117H122O22として、 C 74.74 H 6.54
測 定 値 C 74.23 H 6.50
〔α〕D=+20.0゜(C=0.39、CHCl3)
実施例 2
(3)260mgをTHF20mlに溶解し、0.01N
NaOMe/MeOH30mlを加え、1晩室温で撹拌す
るとtlc(トルエン:酢酸エチル5:1)で原料の
Rf0.86のスポツトが消失し、Rf0.74の単一のスポ
ツトが現れた。アンバーリストA−15で中和後、
溶媒除去し、シリカゲル5gのフラツシユクロマ
トグラフイー(トルエン:酢酸エチル10:1)に
より単離し210mgのシロツプ状物質(4)を得た。Reference example 2 The entire amount of the obtained (17) was dissolved in 500 ml of pyridine,
After adding 180 g (0.65 M) of trityl chloride and stirring overnight at room temperature after purging with nitrogen, the spot near the origin of the raw material almost disappeared on TLC (toluene: ethyl acetate 2:1), and a new spot with Rf0.35 appeared. Ta.
Approximately 400 g of a syrupy substance obtained by removing the solvent was separated by flash chromatography using 500 g of silica gel (500 ml of toluene → toluene: ethyl acetate 2:1) to obtain 302 g of a powdery crude product (18).
I got it. (95% from α-D-mannose) [α] D = +2.1° (C = 0.72, CHCl 3 ) Reference example 3 (18) 2.21g (5mM) was dissolved in 100ml of DMF, and 50% NaH0 was added under ice cooling. Add .76 (33mM) and stir at room temperature for 1 hour. Furthermore, under ice cooling, benzyl bromide 2.7
ml dropwise and stirred at room temperature for 3 hours, the origin spot of the raw material disappears on TLC (toluene) and a new
A spot of Rf0.50 appeared. Under ice cooling, methanol
Add 10 ml and stir at room temperature for 30 minutes. After removing the solvent, add 50 ml of water and extract three times with 50 ml of ether.
After washing with water and saturated brine, dehydration with MgSO 4 , the solvent was removed, and isolation was performed by flash chromatography (toluene) on 100 g of silica gel to obtain 3.0 g of a syrup-like substance (25). (80%) As C 49 H 48 O 6 , C80.30 H 6.60 Measured value C80.46 H 6.56 [α] D = +18.3° (C = 0.88, CHCl 3 ) Reference example 4 (25) 25 g Dissolve in 400ml of acetic acid and add 100ml of water.
After stirring at 100°C for 45 minutes, the Rf0.50 spot of the raw material disappeared on TLC (toluene), and a new Rf0.10 spot appeared along with the Rf0.90 spot. After removing the solvent, a spot with an Rf of 0.10 was isolated by flash chromatography (toluene:ethyl acetate 4:1) using 300 g to obtain 15 g of a syrupy substance (26). (94%) As C 30 H 34 O 6 , C 73.45 H 6.99 C 73.22 H 6.99 [α] D = +37.0° (C = 0.45, CHCl 3 ) Reference example 5 (26) 15 g was mixed with acetic anhydride: Pyridine 1 : When dissolved in 150 ml of a mixed solution of 2 and stirred overnight at room temperature, the Rf0.29 spot of the raw material disappeared on TLC (toluene: ethyl acetate 5:1), and a new single Rf0.56 spot appeared. . After removing the solvent, add 500ml of saturated sodium bicarbonate solution,
After extraction with 400 ml of chloroform three times, wash twice with water, dehydrate with MgSO 4 , remove the solvent, and further extract with ethanol,
Azeotroped three times with toluene to obtain 16.5 g of syrupy substance (2
7) was obtained. (Quantitative) [α] D = +8.4゜ (C = 1.2, CHCl 3 ) As C 32 H 36 O 7 , C 72.16 H 6.81 Measured value C 71.48 H 6.57 Reference example 6 (27) 5 g was added to 40 ml of acetic acid After dissolving 1.2 g of pdCl 2 and adding 1.25 g of sodium acetate and 2 ml of water and stirring at room temperature for 3 days, the Rf0.66 spot of the raw material almost disappeared with TLC (toluene: ethyl acetate 5:1) and a new Rf0.12 was added.
A spot appeared. After passing through diatomaceous earth (FC), the solvent was removed, 300 ml of water was added, and the mixture was extracted three times with 300 ml of ethyl acetate. After washing with saturated sodium bicarbonate solution, water, and saturated saline, drying with MgSO 4 and removing the solvent, silica gel 100
Flash chromatography of g (toluene:
Isolation with ethyl acetate (3.5:1) gave 4.1 g of syrup (28). (88%) [α] D = +10.3 (C = 0.5, CHCl 3 ) C 29 H 32 O 7・2/3CH 3 As COOH C 68.37 H 6.56 Measured value C 68.34 H 6.52 Reference example 7 (28) Dissolve 2g in 40ml dichloromethane
Add 0.1 ml of DMF and 4 ml of thionyl chloride and stir overnight. TLC (toluene: ethyl acetate 5:1)
Above, a new Rf0.71 spot appeared along with a small Rf0.16 spot from the raw material. After removing the solvent, flash chromatography (toluene:ethyl acetate 7:1) was performed on 10 g of silica gel to obtain 1.4 g of a syrupy substance (24). (68%) [α] D = +59.3° (C = 0.77 CHCl 3 ) Example 1 Molecular sieves in a 30ml brown two-necked flask
Add 2 g of 4A powder and stir at 180°C under reduced pressure for 6 hours.
AgOSO 2 CF 3 200 dissolved in 10 ml of toluene after cooling to room temperature
mg and remove the solvent under reduced pressure at 50°C. Compound (1) 290mg dissolved in 15ml dichloroethane after nitrogen substitution
(0.208mM) and cooled to -15℃ (2) 110mg
(0.215mM1.03eq) was dissolved in 5ml of dichloroethane and injected dropwise. After stirring for 3 hours at room temperature, traces of (1) were removed on TLC (toluene:ethyl acetate 10:1).
Along with the Rf0.38 spot, a new Rf0.64 spot appeared. Cool to -15℃ and add 2 ml of dichloroethane.
After adding 20 mg (0.067 mM) of solution (2) and stirring overnight at room temperature, an almost single Rf0.64 spot appeared on TLC (same as above). After evaporation, the solvent was removed and the residue was isolated by flash chromatography on 20 g of silica gel to obtain 310 mg of syrup-like substance (3). (80%) As C 117 H 122 O 22 , C 74.74 H 6.54 Measured value C 74.23 H 6.50 [α] D = +20.0° (C = 0.39, CHCl 3 ) Example 2 (3) 260 mg in THF 20 ml Dissolved, 0.01N
Add 30ml of NaOMe/MeOH and stir overnight at room temperature.
The Rf0.86 spot disappeared and a single Rf0.74 spot appeared. After neutralization with Amberlyst A-15,
The solvent was removed and isolated by flash chromatography on 5 g of silica gel (toluene:ethyl acetate 10:1) to give 210 mg of syrup (4).
C115H120O21として、 C 75.15 H 6.58
測 定 値 C 74.49 H 6.61
〔α〕D=+12.8゜(C=0.6、 CHCl3)
実施例 3
20ml溶褐色2口フラスコにモレキユラーシーブ
ス4A末1gを入れ減圧下190℃で6時間撹拌す
る。室温に冷却後、トルエン10ml溶の
AgSO3CF360mgを注入し、減圧下40℃で溶媒除去
する。ジクロルエタン10ml溶の(4)105mg
(0.058mM)を注入後−15℃に冷却しジクロルエ
タン1ml溶の(8)100mg(0.189mM)を滴下注入す
る。更に室温で1晩撹拌するとtlc(トルエン:酢
酸エチル10:1)上で(4)のRf0.42のスポツトが消
失し(8)のRf0.52のスポツトと共に新たにRf0.49の
スポツトが現れた。ジクロルメタン30mlで希釈後
過し、溶媒除去後シリカゲル10gのフラツシユ
クロマトグラフイー(トルエン:酢酸エチル10:
1)により単離し、77mgのシロツプ状物質(29)を
得た。(58%)
実施例 4
(29)77mgをTHF5mlに溶解し、0.1N NaOMe/
MeOH 5mlを加え室温で8時間撹拌するとtlc
(トルエン:酢酸エチル5:1)上で(29)の
Rf0.74のスポツトが消失し、新たにRf0.59の単一
のスポツトが現れた。アンバーリストA−15で中
和後、溶媒除去しシリカゲル15gのフラツシユク
ロマトグラフイーにより単離し60mgのシロツプ状
物質(30)を得た。As C 115 H 120 O 21 , C 75.15 H 6.58 Measured value C 74.49 H 6.61 [α] D = +12.8° (C = 0.6, CHCl 3 ) Example 3 Molecular sieves in a 20 ml melt brown two-necked flask Add 1 g of 4A powder and stir at 190°C under reduced pressure for 6 hours. After cooling to room temperature, add 10ml of toluene solution.
Inject 60 mg of AgSO 3 CF 3 and remove the solvent under reduced pressure at 40°C. 105 mg of (4) dissolved in 10 ml of dichloroethane
After injecting (0.058mM), the mixture was cooled to -15°C, and 100mg (0.189mM) of (8) dissolved in 1ml of dichloroethane was injected dropwise. Further, after stirring overnight at room temperature, the Rf0.42 spot in (4) disappeared on TLC (toluene:ethyl acetate 10:1), and a new Rf0.49 spot appeared along with the Rf0.52 spot in (8). Ta. Dilute with 30 ml of dichloromethane, filter, remove the solvent, and perform flash chromatography on 10 g of silica gel (toluene: ethyl acetate 10:
1), yielding 77 mg of a syrupy substance (29). (58%) Example 4 Dissolve 77mg of (29) in 5ml of THF and add 0.1N NaOMe/
Add 5 ml of MeOH and stir at room temperature for 8 hours.
(29) on (toluene:ethyl acetate 5:1)
The Rf0.74 spot disappeared, and a new single Rf0.59 spot appeared. After neutralization with Amberlyst A-15, the solvent was removed and the mixture was isolated by flash chromatography on 15 g of silica gel to obtain 60 mg of a syrupy substance (30).
C142H145O26として、 C 75.11 H 6.57
測 定 値 C 75.11 H 6.57
〔α〕D=+34.5゜(C=0.17 CHCl3)
実施例 5
(30)55mgを酢酸10mlに溶解し10%pd−C30mgを
加え50℃で6時間水素添加するとtlc(ブタノー
ル:酢酸:水2:1:1)上で原料のスポツトが
消失し、新たにRf0.16のスポツトが現れた。ケイ
藻土(FC)過後、層を水洗し、洗液と共に
溶媒除去後20gのセフアデツクスG25g(H2O)
のゲル過により単離し、17mgの粉末状物質(31)
を得た。As C 142 H 145 O 26 , C 75.11 H 6.57 Measured value C 75.11 H 6.57 [α] D = +34.5° (C = 0.17 CHCl 3 ) Example 5 Dissolve 55 mg of (30) in 10 ml of acetic acid and make 10% When 30 mg of PD-C was added and hydrogenated at 50°C for 6 hours, the raw material spot disappeared on TLC (butanol:acetic acid:water 2:1:1), and a new spot with Rf0.16 appeared. After passing through diatomaceous earth (FC), the layer was washed with water, and after removing the solvent along with the washing solution, 20g of Cephadex G25g (H 2 O) was added.
17 mg of powdered material (31)
I got it.
〔α〕D=+27.2゜(C=0.4、水)
δC(D2O):102.48( 1JCH170.9Hz、C−1d、C−1e)
100.87( 1JCH169.7Hz、C−1b、C−1e)
92.70(C−1a)
δH(D2O at 63゜):5.351(H−1a)(d、J=2Hz
)
5.273(H−1b、H−1c)(d、J=2Hz)
5.158(H−1e)(d、J=2Hz)
5.054(H−1d)(d、J=2Hz)
実施例 6
30ml溶褐色2口フラスコにモレキユラーシーブ
ス4A末1gを入れ、減圧下190℃で1晩撹拌す
る。室温冷却後トルエン2ml溶のAgSO3CF3150
mgを注入し、減圧下室温で溶媒除去する。続いて
ジクロルエタン10ml溶の(4)250mg(1.36mM)を
注入し、−15゜に冷却しジクロルエタン2ml溶の(2
4)150mg(0.269mM)を滴下注入する。室温で1
晩撹拌するとtlc(トルエン:酢酸エチル10:1)
上で(4)のRf0.35のスポツトが消失し、(24)の
Rf0.49のスポツトと共にRf0.46及びRf0.49のスポ
ツトが目測で1:4の濃度比で現れた。ジクロル
エタン50mlで希釈後過し、溶媒除去後シリカゲ
ル25gのフラツシユクロマトグラフイー(トルエ
ン:酢酸エチル12:1)によりRf0.46のものと
Rf0.49のものの混合物を350mgのシロツプ状物質
(32)として分離した。 [α] D = +27.2゜ (C = 0.4, water) δ C (D 2 O): 102.48 ( 1 J CH 170.9Hz, C-1d, C-1e) 100.87 ( 1 J CH 169.7Hz, C- 1b, C-1e) 92.70 (C-1a) δ H (D 2 O at 63°): 5.351 (H-1a) (d, J=2Hz
) 5.273 (H-1b, H-1c) (d, J = 2Hz) 5.158 (H-1e) (d, J = 2Hz) 5.054 (H-1d) (d, J = 2Hz) Example 6 30ml Melted brown Put 1 g of molecular sieves 4A powder into a 2-necked flask and stir overnight at 190°C under reduced pressure. AgSO 3 CF 3 150 dissolved in 2 ml of toluene after cooling to room temperature
mg and remove the solvent under reduced pressure at room temperature. Next, 250 mg (1.36 mM) of (4) dissolved in 10 ml of dichloroethane was injected, cooled to -15°, and (2) dissolved in 2 ml of dichloroethane was injected.
4) Inject 150mg (0.269mM) dropwise. 1 at room temperature
After stirring overnight, TLC (toluene: ethyl acetate 10:1)
Above, the Rf0.35 spot in (4) disappears, and the spot in (24)
Along with the Rf0.49 spot, Rf0.46 and Rf0.49 spots appeared at a concentration ratio of 1:4 as determined by eye. After diluting with 50 ml of dichloroethane and filtering, after removing the solvent, it was determined to have Rf0.46 by flash chromatography on 25 g of silica gel (toluene: ethyl acetate 12:1).
A mixture with Rf 0.49 was isolated as 350 mg of syrup (32).
実施例 7
(32)全量をTHF10mlに溶解し、0.1N
NaOMe/MeOH溶液10mlを加え室温で3時間撹
拌すると、tlc(トルエン:酢酸エチル10:1)上
で原料の2スポツトが消失し、新たにRf0.42及び
0.39の2スポツトが濃度比4:1で現れた。p−
tlc(preparative−tlc)(トルエン:酢酸エチル
10:1)でRf0.42のものを単離し、150mgのシロ
ツプ状物質(33)を得た。Example 7 (32) Dissolve the entire amount in 10ml of THF and add 0.1N
After adding 10 ml of NaOMe/MeOH solution and stirring at room temperature for 3 hours, two spots of the raw material disappeared on TLC (toluene: ethyl acetate 10:1), and new Rf0.42 and
Two spots of 0.39 appeared with a concentration ratio of 4:1. p-
tlc (preparative-tlc) (toluene: ethyl acetate
10:1) and Rf 0.42 was isolated, yielding 150 mg of a syrupy substance (33).
C142H148O26として、C 75.11 H 6.57 測 定 値 C 74.96 H 6.68 〔α〕D=+26.0゜(C=1.99、CHCl3)As C 142 H 148 O 26 , C 75.11 H 6.57 Measured value C 74.96 H 6.68 [α] D = +26.0° (C = 1.99, CHCl 3 )
Claims (1)
ド。 式中、Rは水素またはベンジル基を表わし、
R1、R2、R3及びR4は水素、ベンジル基またはア
セチル基を表わし、同一でも異なつていてもよ
い。 2 式 (式中Rはベンジル基を表わす) で表わされる化合物と式 (R1、R2、R3、R4はアセチル基またはベンジル
基、Xはハロゲン原子を表わす) で表わされる化合物を反応させ、必要により脱ア
セチル化及び脱ベンジル化して一般式 (式中、Rは水素またはベンジル基を表わし、
R1、R2、R3、R4は水素、ベンジル基またはアセ
チル基を表わす) で表わされる化合物を得ることを特徴とするオリ
ゴマンノシドの製造法。 3 式 (Rはベンジル基を表わす) で表わされる化合物と、式 (Rはベンジル基、Acはアセチル基、Xはハロ
ゲン原子を表わす) で表わされる化合物を反応させて、式 (Rはベンジル基、Acはアセチル基を表わす) で表わされる化合物を得、これを脱アセチル化し
て得られる化合物と、式 (R1、R2、R3、R4はアセチル基またはベンジル
基、Xはハロゲン原子を表わす) で表わされる化合物を反応させ、必要により脱ア
セチル化及び脱ベンジル化して一般式 (式中、Rは水素またはベンジル基を表わし、
R1、R2、R3、R4は水素、ベンジル基またはアセ
チル基を表わす) で表わされる化合物を得ることを特徴とするオリ
ゴマンノシドの製造法。[Claims] 1. An oligomannoside represented by the following general formula. In the formula, R represents hydrogen or a benzyl group,
R 1 , R 2 , R 3 and R 4 represent hydrogen, a benzyl group or an acetyl group, and may be the same or different. 2 formulas (In the formula, R represents a benzyl group) Compounds and formulas represented by (R 1 , R 2 , R 3 , R 4 are an acetyl group or a benzyl group, and X is a halogen atom) are reacted, deacetylated and debenzylated as necessary, and the general formula (In the formula, R represents hydrogen or a benzyl group,
R 1 , R 2 , R 3 , and R 4 represent hydrogen, a benzyl group, or an acetyl group. 3 formulas (R represents a benzyl group) and a compound represented by the formula (R is a benzyl group, Ac is an acetyl group, and X is a halogen atom) by reacting a compound represented by the formula (R represents a benzyl group, Ac represents an acetyl group) A compound obtained by deacetylating this and a compound of the formula (R 1 , R 2 , R 3 , R 4 are an acetyl group or a benzyl group, and X is a halogen atom) are reacted, deacetylated and debenzylated as necessary, and the general formula (In the formula, R represents hydrogen or a benzyl group,
R 1 , R 2 , R 3 , and R 4 represent hydrogen, a benzyl group, or an acetyl group.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14666282A JPS5936690A (en) | 1982-08-24 | 1982-08-24 | New oligomannoside and its production method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14666282A JPS5936690A (en) | 1982-08-24 | 1982-08-24 | New oligomannoside and its production method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5936690A JPS5936690A (en) | 1984-02-28 |
| JPH0259836B2 true JPH0259836B2 (en) | 1990-12-13 |
Family
ID=15412781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP14666282A Granted JPS5936690A (en) | 1982-08-24 | 1982-08-24 | New oligomannoside and its production method |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5936690A (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2802536B1 (en) | 1999-11-23 | 2003-06-13 | Chru Lille | SYNTHESIS OLIGOMANNOSIDES, THEIR PREPARATION AND THEIR USE FOR THE DETECTION OF ANTIBODIES AND THE PREVENTION OF INFECTIONS |
| JP4122493B2 (en) | 2001-04-04 | 2008-07-23 | 株式会社共立 | Anti-vibration support structure for vaporizer |
-
1982
- 1982-08-24 JP JP14666282A patent/JPS5936690A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5936690A (en) | 1984-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Murakata et al. | Stereoselective total synthesis of the glycosyl phosphatidylinositol (GPI) anchor of Trypanosoma brucei | |
| FR2535324A1 (en) | PERFECTED STATION FOR THE PURIFICATION OF WASTEWATER | |
| JPH0899989A (en) | New glycolipid derivative and intermediate for its production | |
| Zhu et al. | A highly efficient synthetic strategy for polymeric support synthesis of lex, ley, and H‐type 2 oligosaccharides | |
| CA1265792A (en) | Oligosaccharides, synthesis process and biological uses thereof | |
| Du et al. | An efficient and concise regioselective synthesis of α-(1→ 5)-linked L-arabinofuranosyl oligosaccharides | |
| FR2773801A1 (en) | New synthetic pentasaccharides with antithrombotic activity - have antifactor Xa activity and affinity for antithrombin III | |
| FI87573B (en) | FOER REFRIGERATION FOR EXAMINATION OF GANGLIOSIDLIKA FOERENINGAR | |
| Zhu et al. | A facile and effective synthesis of α-(1→ 6)-linked mannose di-, tri-, tetra-, hexa-, octa-, and dodecasaccharides, and β-(1→ 6)-linked glucose di-, tri-, tetra-, hexa-, and octasaccharides using sugar trichloroacetimidates as the donors and unprotected or partially protected glycosides as the acceptors | |
| JPH0651715B2 (en) | Sialosyl cerebrosides and method for producing the same | |
| CN113980063A (en) | A kind of preparation method of six-carbon sugar-curcumin derivative | |
| JPH11255794A (en) | Fullerene derivative and its production | |
| JPH0261960B2 (en) | ||
| JPH0425277B2 (en) | ||
| KR20240097876A (en) | Novel oligosaccharides, intermediates for producing the oligosaccharides, and methods for producing them | |
| JPS6364437B2 (en) | ||
| EP0082793B1 (en) | Derivatives with a uronic acid structure, their preparation and their biological applications | |
| Takeo et al. | Synthesis of 8-Methoxycarbonyloctylβ-Glycosides of Tri-and Tetrasaccharides Related to Schizophyllan and Neoglycoproteins Therefrom | |
| JPH08245678A (en) | Disaccharide monomer and its oligomer and method for producing oligomer | |
| JPH0425275B2 (en) | ||
| Hada et al. | Syntheses of model compounds related to an antigenic epitope in pectic polysaccharides from Bupleurum falcatum L. | |
| JPH03264595A (en) | Novel glycosylation method | |
| HU207337B (en) | Process for producing tetrasaccharides | |
| JPH0441154B2 (en) | ||
| JPH0425276B2 (en) |